Using rAAV2-retro in rhesus macaques: Promise and caveats for circuit manipulation.

Journal of Neuroscience Methods
Adriana K CushnieSarah R Heilbronner

Abstract

Recent genetic technologies such as opto- and chemogenetics allow for the manipulation of brain circuits with unprecedented precision. Most studies employing these techniques have been undertaken in rodents, but a more human-homologous model for studying the brain is the nonhuman primate (NHP). Optimizing viral delivery of transgenes encoding actuator proteins could revolutionize the way we study neuronal circuits in NHPs. NEW METHOD: rAAV2-retro, a popular new capsid variant, produces robust retrograde labeling in rodents. Whether rAAV2-retro's highly efficient retrograde transport would translate to NHPs was unknown. Here, we characterized the anatomical distribution of labeling following injections of rAAV2-retro encoding opsins or DREADDs in the cortico-basal ganglia and oculomotor circuits of rhesus macaques. rAAV2-retro injections in striatum, frontal eye field, and superior colliculus produced local labeling at injection sites and robust retrograde labeling in many afferent regions. In every case, however, a few brain regions with well-established projections to the injected structure lacked retrogradely labeled cells. We also observed robust terminal field labeling in downstream structures. Patterns of labeling were sim...Continue Reading

References

May 1, 1979·Journal of Neuropathology and Experimental Neurology·H Tsiang
May 22, 1988·The Journal of Comparative Neurology·G B StantonC J Bruce
Jan 1, 1972·The Journal of Comparative Neurology·M B Carpenter, P Peter
Oct 1, 1966·Journal of Neurology, Neurosurgery, and Psychiatry·W M Cowan, T P Powell
Aug 15, 1980·The Journal of Comparative Neurology·J K HartingG J Royce
Aug 3, 1999·Biological Chemistry·H Büeler
Nov 14, 2000·Molecular Medicine Today·P E Monahan, R J Samulski
Aug 21, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·C SoudaisE J Kremer
Jan 12, 2002·Molecular Therapy : the Journal of the American Society of Gene Therapy·Brian K KasparDaniel A Peterson
Feb 28, 2002·The European Journal of Neuroscience·M TakadaA Nambu
Oct 14, 2005·Progress in Brain Research·Paul J May
Aug 11, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Suzanne N HaberRoberta Calzavara
Oct 17, 2006·Journal of Virology·Vivian W ChoiR Jude Samulski
Mar 9, 2007·Human Gene Therapy·Jean-Marc TaymansVeerle Baekelandt
Feb 1, 2008·IEEE Transactions on Bio-medical Engineering·Angel V PeterchevSarah H Lisanby
May 24, 2008·Human Vaccines·Peggy MarconiRoberto Manservigi
Jun 5, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Janet CunninghamKrystof S Bankiewicz
Aug 21, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Cassia N CearleyJohn H Wolfe
Dec 1, 2009·Nature Reviews. Microbiology·Matthias J SchnellAmy Papaneri
Dec 3, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Francesca SimonelliAlberto Auricchio
Mar 16, 2012·Gene Therapy·E A SalegioK S Bankiewicz
Jun 23, 2012·Nature·Masaharu KinoshitaTadashi Isa
Aug 10, 2012·Frontiers in Microbiology·Masako NomaguchiAkio Adachi
Dec 12, 2012·Neuron·James CavanaughRobert H Wurtz
Jan 29, 2013·Frontiers in Neural Circuits·Melanie GingerAndreas Frick

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.